Abstract:Lytic bacteriophages hold substantial promise in medical and biotechnological applications. Therefore a comprehensive understanding of phage infection mechanisms is crucial. CRISPR-Cas systems offer a way to explore these mechanisms via site-specific phage mutagenesis. However, phages can resist Cas-mediated cleavage through extensive DNA modifications like cytosine glycosylation, hindering mutagenesis efficiency. Our study utilizes the eukaryotic enzyme NgTET to temporarily reduce phage DNA modifications, facilitating Cas nuclease cleavage and enhancing mutagenesis efficiency. This approach enables precise DNA targeting and seamless point mutation integration, exemplified by deactivating specific ADP-ribosyltransferases crucial for phage infection. Furthermore, by temporally removing DNA modifications, we elucidated the effects of these modifications on T4 phage infections without necessitating gene deletions. Our results present a strategy enabling the investigation of phage epigenome functions and streamlining the engineering of phages with cytosine DNA modifications. The described temporal modulation of the phage epigenome is valuable for synthetic biology and fundamental research to comprehend phage infection mechanisms through the generation of mutants. Bacteriophages, viruses that target bacteria, hold substantial promise for applications in biotechnological and medical settings. A comprehensive understanding of their infection mechanisms is essential for harnessing their full potential in these fields. To study the mechanisms underlying efficient phage infection, mutagenesis of the bacteriophage genome is the key. While CRISPR-Cas offers a powerful tool for performing mutagenesis in various organisms in a site-specific manner, its application is limited to bacteriophages due to the extensive modification of bacteriophage DNA, collectively termed the epigenome. For bacteriophages with highly modified genomes, e. g. bacteriophage T4, the DNA modifications impede Cas nuclease targeting–a crucial step in CRISPR-Cas mutagenesis. In our study, we introduce a temporal modulation of the bacteriophage epigenome, allowing us to decrease the abundance of bacteriophage DNA modifications. This approach enables the investigation of the biological role of the bacteriophage epigenome and allows for its efficient targeting by Cas nucleases, permitting successful phage mutagenesis. Our approach to modulating the bacteriophage epigenome not only deepens the understanding of bacteriophage infection mechanisms through mutagenesis but also holds significant potential for synthetic biology. This advancement paves the way for the efficient engineering of phages, enhancing their application in biotechnological and medical fields.

Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.

The complex roles of genomic DNA modifications of bacteriophage T4 in resistance to nuclease-based defense systems of E. coli

Bacteriophage T4 Escapes CRISPR Attack by Minihomology Recombination and Repair

Unexpected Evolutionary Benefit to Phages Imparted by Bacterial CRISPR-Cas9.

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

Molecular mechanisms of CRISPR-mediated microbial immunity

CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage

Strengthening Phage Resistance of Streptococcus thermophilus by Leveraging Complementary Defense Systems

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

The effect of phage genetic diversity on bacterial resistance evolution

CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea

My host's enemy is my enemy: plasmids carrying CRISPR-Cas as a defence against phages

CRISPR-Cas supervises diverse anti-phage defense systems

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage

How the other half lives: CRISPR-Cas's influence on bacteriophages

CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool

A Type IV restriction system targets glucosylated 5-hydroxyl methyl cytosine to protect against phage infection

Physical Model of the Immune Response of Bacteria Against Bacteriophage Through the Adaptive CRISPR-Cas Immune System

Temporal epigenome modulation enables efficient bacteriophage engineering and functional analysis of phage DNA modifications

The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies